tera.ai

Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

All entities

Entity

KRAS-mutated recurrent low-grade serous ovarian cancer

market1 mentionslast seen Oct 14, 2026

Indication for AVMAPKI FAKZYNJA CO-PACK approved by FDA.

Relationships 1

KRAS-mutated recurrent low-grade serous ovarian cancer

Relationship

AVMAPKI FAKZYNJA CO-PACKapplies toKRAS-mutated recurrent low-grade serous ovarian cancer

98% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1